Strong Q3 Performance in P&C
The P&C segment delivered an excellent performance with a combined ratio of 80.9%, well ahead of the forward 2026 assumption of below 87%. The low Cat claims and slightly higher attritional loss ratio contributed to these results.
Impressive Net Income and Return on Equity
SCOR reported EUR 211 million of net income for Q3, with a return on equity of 21.5%. On a 9-month basis, the net income stands at EUR 631 million, translating into a return on equity of 19.5%.
Significant Growth in Economic Value
Economic value increased by 12.7% at constant economics, indicating robust business performance in both P&C and Life and Health segments.
Investment Performance
Achieved a 3.5% regular income yield, supported by a high-quality fixed income portfolio benefiting from elevated reinvestment rates.